More on Trinity Biotech Q2 results

Trinity Biotech (TRIB +0.7%) Q2 results: Revenues: $26.0M (+22.1%); Operating Income: $4.6M (+24.3%); Net Income: $4.3M (+13.2%); Earnings per ADR: $0.182 (+7.7%); Quick Assets: $15.2M (-10.6%); CF Ops: $1.6M (-23.8%).

106 Premier instruments placed or sold, 207 in 1H. FY Goal: 460.

No guidance given.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs